Impairment losses on fixed assets in the Japan segment
First written in FY2021-Q1. 1 of 10 entries say "Mitigated", first in FY2026. Latest entry: FY2026.
0 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「The company recorded an impairment loss of ¥43 million during the current consolidated fiscal year.」
The impairment loss on property, plant and equipment decreased from ¥51 million in the previous fiscal year to ¥43 million, reducing the full-year amount recorded. - FY2024Substantial full-year reduction in impairment lossesAnnual report
「The company recorded an impairment loss of ¥118 million during the current consolidated fiscal year.」
The FY2024 impairment loss was ¥118 million, a substantial decrease from ¥965 million in the previous fiscal year. However, the company recorded an impairment loss on operating assets related to ロートウェルコート because of deteriorating profitability. - FY2024-Q3No impairment loss recorded in the third quarterAnnual report
「There are no applicable matters.」
The segment information for the cumulative third quarter contains no impairment loss on property, plant and equipment or goodwill, and no impairment loss was identified. - FY2023Recognition of full-year impairment lossesAnnual report
「The company recorded an impairment loss of ¥965 million during the current consolidated fiscal year.」
For FY2023, the company recorded impairment losses of ¥691 million at 摩耶堂製薬 and ¥274 million at 天藤製薬, for a total of ¥965 million. This was an increase from ¥892 million in the previous fiscal year. - FY2023-Q3No impairment loss recognizedAnnual report
「There are no applicable matters.」
The segment information for the cumulative third quarter contains no impairment loss on property, plant and equipment, down from the ¥51 million recorded by the Japan segment in the same period of the previous year. - FY2022-Q3Reduction in impairment lossesAnnual report
「The Japan segment recorded an impairment loss on property, plant and equipment. The amount recorded was ¥51 million for the cumulative third quarter of the current consolidated fiscal year.」
The Japan segment's impairment loss on property, plant and equipment was ¥51 million for the cumulative third quarter, a substantial decrease from ¥1.435 billion in the same period of the previous year. - FY2021Increase in Full-Year Impairment LossesAnnual report
「Impairment loss ¥1,609 million」
The full-year impairment loss was ¥1,609 million. The Japan segment accounted for ¥1,536 million, further increasing from the cumulative amount through the same period of the previous year. - FY2021-Q3Increase in impairment lossesAnnual report
「In the Japan segment, an impairment loss on property, plant and equipment was recorded. The impairment loss recorded was ¥1,435 million for the first 3 quarters of the fiscal year.」
The Japan segment's impairment loss on property, plant and equipment increased to ¥1.435 billion for the cumulative third quarter, from ¥379 million for the cumulative second quarter. - FY2021-Q2Increase in impairment lossesAnnual report
「In the Japan segment, an impairment loss on property, plant and equipment was recorded. The impairment loss recorded was ¥379 million for the first 2 quarters of the fiscal year.」
The Japan segment's impairment loss on property, plant and equipment increased to ¥379 million for the cumulative second quarter, from ¥125 million in the first quarter. - FY2021-Q1First statedAnnual report
「The Japan segment recorded an impairment loss on property, plant and equipment. The amount recorded was ¥125 million for the cumulative first quarter of the current consolidated fiscal year.」
The company recorded a ¥125 million impairment loss on property, plant and equipment in the Japan segment during the first quarter.